Age- and sex-specific rates of leukoaraiosis in TIA and stroke patients
Population-based study
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: To determine any sex differences in age-specific prevalence or severity of leukoaraiosis, a marker of white matter ischemia, in population-based and clinic cohorts of TIA/stroke and in a systematic review of the literature.
Methods: Age-specific sex differences were calculated for both CT and MRI in the Oxford Vascular Study (OXVASC) and in an MRI-based clinic cohort. We pooled odds ratios (ORs) for leukoaraiosis in women vs men from published studies by fixed-effect meta-analysis, stratified by patient characteristics (stroke vs nonstroke) and CT vs MRI.
Results: Among 10 stroke studies (all CT-based), leukoaraiosis was most frequent in women (OR = 1.42, 95% confidence interval [CI] 1.27–1.57, p < 0.0001), with little heterogeneity between studies (p = 0.28). However, no such excess was seen in 10 reports of nonstroke cohorts (0.91, 0.67–1.24, p = 0.56). Moreover, excess leukoaraiosis in women on CT-imaging in OXVASC (1.38, 1.15–1.67, p = 0.001) was explained by their older age (age-adjusted OR = 1.01, 0.82–1.25, p = 0.90). Leukoaraiosis was more severe in older (≥75) women (CT-1.50, 1.14–1.97, p = 0.004 in OXVASC; MRI-1.70, 1.17–2.48, p = 0.006 in OXVASC and clinic cohort). However, leukoaraiosis was independently associated with early mortality (hazard ratio = 1.46, 1.23–1.73, p < 0.0001), suggesting that comparisons in older age groups will be biased by prior premature death of men with leukoaraiosis. Sex differences in severity of leukoaraiosis were not addressed in previous studies.
Conclusions: Previously reported excess leukoaraiosis in women with TIA/stroke is likely to be confounded by age and apparently greater severity in older women is likely to be biased by premature death in men with leukoaraiosis.
GLOSSARY
- CI=
- confidence interval;
- OR=
- odds ratio;
- OXVASC=
- Oxford Vascular Study
Footnotes
Study funding: The Oxford Vascular Study is funded by the UK Medical Research Council, the National Institute of Health Research (NIHR), the Stroke Association, the Dunhill Medical Trust, the NIHR Biomedical Research Centre, Oxford, and the Wellcome Trust. Dr. Ursula G. Schulz is funded by an NIHR Clinician Scientist Fellowship.
See page 1208
Supplemental data at www.neurology.org
- Received December 1, 2011.
- Accepted May 1, 2012.
- Copyright © 2012 by AAN Enterprises, Inc.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Dennis Bourdette and Dr. Lindsey Wooliscroft
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Article
Leukoaraiosis, intracerebral hemorrhage, and functional outcome after acute stroke thrombolysisKannikar Kongbunkiat, Duncan Wilson, Narongrit Kasemsap et al.Neurology, January 27, 2017 -
Articles
Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute strokeV. Palumbo, J. M. Boulanger, M. D. Hill et al.Neurology, March 26, 2007 -
Articles
Significant association between leukoaraiosis and metabolic syndrome in healthy subjectsK. Park, N. Yasuda, S. Toyonaga et al.Neurology, May 30, 2007 -
Articles
Silent brain infarcts, leukoaraiosis, and long-term prognosis in young ischemic stroke patientsJ. Putaala, E. Haapaniemi, M. Kurkinen et al.Neurology, May 16, 2011